-+ 0.00%
-+ 0.00%
-+ 0.00%

Iterum Therapeutics Q1 Adj. EPS $(0.10) Beats $(0.14) Estimate

Benzinga·05/13/2025 11:01:18
Listen to the news
Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.14) by 28.57 percent. This is a 73.68 percent increase over losses of $(0.38) per share from the same period last year.